|
Volumn 51, Issue 3, 2010, Pages 207-212
|
Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CVAD PROTOCOL;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
EPOCH PROTOCOL;
ETOPOSIDE;
METHOTREXATE;
PREDNISONE;
VINCRISTINE;
ADULT;
ARTICLE;
B CELL LYMPHOMA;
BURKITT LYMPHOMA;
CASE REPORT;
COLON TUMOR;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
MALE;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
BURKITT LYMPHOMA;
COLONIC NEOPLASMS;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
HUMANS;
LYMPHOMA, AIDS-RELATED;
MALE;
METHOTREXATE;
PREDNISONE;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 77952301490
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|